- Sinopharm is now widely accessible in clinics and private hospitals throughout the country.
- The Sinopharm vaccination is presently indicated for those aged 18 to 59
China’s Sinopharm Covid-19 Vaccine Now Available In Malaysia
According to Duopharma Biotech Bhd, the Sinopharm COVID-19 vaccination is currently accessible in Malaysia.
Duopharma’s fully owned subsidiary, Duopharma (M) Sdn Bhd, has been authorised to act as Sinopharm’s registration holder and to sell and distribute the vaccine throughout the country.
According to a statement issued today by Duopharma, the first shipment of the vaccine came in batches in September 2021 and is now widely accessible in clinics and private hospitals throughout the country.
Group Managing Director Leonard Ariff Abdul Shatar said, “duopharma is committed to supporting the government’s vaccination programme and augmenting the National COVID-19 Immunisation Programme by expanding vaccine distribution channels to ensure full vaccine coverage in Malaysia.”
source - reuters
The Sinopharm vaccination is presently indicated for those aged 18 to 59, according to the statement.
The Drug Control Authority (DCA) of the Ministry of Health granted the conditional registration of Sinopharm COVID-19 vaccine for use in Malaysia in July 2021.